(Q34768804)

4 August 2017

1 reference

title

New strategies for the identification of drugs to prevent the development or progression of epilepsy (English)

1 reference

4 August 2017

Dieter Schmidt

1

1 reference

4 August 2017

Michael A Rogawski

series ordinal

2

1 reference

4 August 2017

publication date

1 June 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

50

1 reference

4 August 2017

issue

1-2

1 reference

4 August 2017

page(s)

71-78

1 reference

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Relapse following discontinuation of antiepileptic drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Strategies for the development of drugs for pharmacoresistant epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Animal models of intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

The clinical impact of new antiepileptic drugs after a decade of use in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Inhibition or enhancement of kindling evolution by antiepileptics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Discontinuation of antiepileptic drugs after successful epilepsy surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Antiepileptogenic agents: how close are we?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900070-0

7 January 2021

10.1016/S0920-1211(02)00070-0

Identifiers

DOI

1 reference

4 August 2017

1 reference